Oxygenta Pharmaceutical Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	4.19	0.02	0.02	0.18	0.72
Short-Term Investments	-	-	-	-	0.89	0.84
Cash & Short-Term Investments	21.49	4.19	0.02	0.02	1.06	1.56
Cash Growth	1664.37%	24547.06%	0%	-98.40%	-31.78%	-65.02%
Accounts Receivable	-	100.28	50.98	73.61	101.6	15.76
Other Receivables	-	-	-	22.7	-	-
Receivables	-	100.28	50.98	96.31	101.6	15.76
Inventory	-	294.21	205.13	137.17	117.05	72.83
Prepaid Expenses	-	-	-	0.4	0.24	0.11
Other Current Assets	-	115.62	53.3	7.17	30.11	5.38
Total Current Assets	-	514.3	309.43	241.06	250.06	95.64
Property, Plant & Equipment	-	475.99	370.65	293.58	279.13	203.2
Long-Term Investments	-	4.74	0.49	0.49	0.49	0.49
Long-Term Accounts Receivable	-	17.69	10.83	-	3.97	3.68
Long-Term Deferred Tax Assets	-	174.07	129.83	87.33	-	-
Other Long-Term Assets	-	10.02	6.81	5.26	4.79	4.55
Total Assets	-	1,197	828.04	631.92	542.65	311.76
Accounts Payable	-	487.69	297.94	228.87	237.8	64.59
Accrued Expenses	-	19.36	18.75	19.13	33.78	5.23
Short-Term Debt	-	314.33	399.41	74.63	49.71	10.86
Current Portion of Long-Term Debt	-	28.47	7.69	7.69	7.7	-
Other Current Liabilities	-	11.11	134.69	6.62	-	-
Total Current Liabilities	-	860.97	858.47	336.95	328.98	80.68
Long-Term Debt	-	752.86	215.22	490.02	622.53	510.43
Pension & Post-Retirement Benefits	-	7.91	8.25	4.8	4.08	2.92
Long-Term Deferred Tax Liabilities	-	-	-	-	16.59	14.61
Other Long-Term Liabilities	-	1.94	2.5	1.38	32.47	49.41
Total Liabilities	-	1,624	1,084	833.15	1,005	658.05
Common Stock	-	369.84	369.84	334.84	142.01	142.01
Additional Paid-In Capital	-	115.91	115.91	96.41	-	-
Retained Earnings	-	-917.51	-741.79	-638.81	-604.01	-488.3
Comprehensive Income & Other	-	4.89	-0.36	6.34	-	-
Shareholders' Equity	-426.87	-426.87	-256.41	-201.22	-462	-346.29
Total Liabilities & Equity	-	1,197	828.04	631.92	542.65	311.76
Total Debt	1,096	1,096	622.32	572.34	679.94	521.29
Net Cash (Debt)	-1,074	-1,091	-622.31	-572.32	-678.87	-519.73
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-29.06	-29.51	-17.31	-17.86	-47.80	-40.78
Filing Date Shares Outstanding	36.98	36.98	36.98	33.48	14.2	14.2
Total Common Shares Outstanding	36.98	36.98	36.98	33.48	14.2	14.2
Working Capital	-	-346.67	-549.05	-95.89	-78.92	14.96
Book Value Per Share	-11.55	-11.54	-6.93	-6.01	-32.53	-24.38
Tangible Book Value	-426.87	-426.87	-256.41	-201.22	-462	-346.29
Tangible Book Value Per Share	-11.55	-11.54	-6.93	-6.01	-32.53	-24.38
Land	-	1.82	1.82	1.82	1.82	1.82
Buildings	-	122.76	95.74	78.45	70.43	57.66
Machinery	-	621.27	517.36	425.07	392.04	304.93
Construction In Progress	-	-	2.34	-	-	3.43